Zobrazeno 1 - 10
of 666
pro vyhledávání: '"First, MR"'
Publikováno v:
Journal of Biochemistry and Analytical studies. 4
Autor:
First Mr
Publikováno v:
Transplantation Proceedings. 33:806-810
Publikováno v:
Gynecologic Oncology. 79:220-224
Objective. Immunocompromised patients, such as female renal transplant recipients, have an increased incidence of neoplasms involving the lower genital tract (i.e., cervix, vagina, vulva). The relationship between lower genital tract neoplasms and hu
Publikováno v:
Therapeutic Drug Monitoring. 22:330-345
The immunosuppressant cyclosporine is generally considered a critical-dose drug. The validity of standard criteria to establish bioequivalence between cyclosporine formulations has recently been challenged. Recommendations included establishment of i
Autor:
Israel Penn, First Mr
Publikováno v:
Transplantation. 68:1717-1721
In the general population Merkel’s cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer. More than 600 cases have been reported. MCC seems to be common in transplant recipients, with 41 cases being reported to the Cincinnati Transplant
Autor:
Arthur J. Matas, Nancy L. Reinsmoen, Lawrence G. Hunsicker, Lynn Donaldson, J. W. Alexander, Stephen Rose, First Mr, Francis L. Delmonico, Alan H. Wilkinson, Thistlethwaite, Arnold G. Diethelm, Rosenthal Jt, Jimmy A. Light
Publikováno v:
Transplantation. 68:1117-1124
BACKGROUND The beneficial effects of donor specific transfusion (DST) have become controversial in the cyclosporine era. This study was performed to evaluate the potential benefits of a new protocol for administering DSTs in the perioperative period.
Publikováno v:
Transplantation. 68:642-645
Background. We sought to determine whether diagnoses established through the Banff schema for evaluation of renal allograft pathology have implications for clinical management, compared with diagnoses established using descriptive terminology. Method
Publikováno v:
Transplantation. 67:1411-1417
Background Neoral, a microemulsion formulation of cyclosporine, was approved for use in the United States in 1995. Many studies comparing Neoral and Sandimmune have been conducted, and although most state that Neoral is the superior cyclosporine form
Publikováno v:
Transplantation Proceedings. 31:1S-6S
In this study intended to establish equivalence between two antibody therapies for acute rejection in kidney transplant recipients, it was important to develop a rigorous protocol. Assurance of the presence of acute rejection was imperative. Therefor
Autor:
Canafax Dm, R. Levy, Uwe Christians, Philippe Pouletty, First Mr, E. C. Squiers, William Irish, Moran Hb
Publikováno v:
Pharmacology. 59:78-88
A novel bioequivalence testing approach was used to determine intrasubject variability and switchability of two ciclosporin formulations, SangCyaTM (test) and Neoral® (reference). Twenty healthy volunteers were enrolled into a single-dose, randomize